The safety and efficacy of interleukin-1 receptor antagonist in the treatment of rheumatoid arthritis

Seminars in Arthritis and Rheumatism

Volumn 30, Issue 5 SUPPL. 2, 2001, Pages 17-20

  Bresnihan, Barry ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Interleukin 1 receptor antagonist; Rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; METHOTREXATE; PLACEBO; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS;

EID: 0035303568     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1053/sarh.2001.23701     Document Type: Article

References (16)

1. Arend WP, Dayer J-M. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis. Arthritis Rheum 1995;38:151-60.
2. Chu CQ, Field M, Allard SA, Abney E, Feldmann M, Maini RN. Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: Implications for the role of cytokines in cartilage destruction and repair. Br J Rheumatol 1992;31:653-61.
3. Wood NC, Dickens E, Symon JA, Duff GW. In situ hybridization of interleukin-1 in CD14-positive cells in rheumatoid arthritis. Clin Immunol Immunopathol 1992;62:295-300.
4. Deleuran BW, Chu CQ, Field M, Brennan FM, Katsikis P, Feldmann M, et al. Localization of interleukin-1α, type 1 interleukin-1 receptor and interleukin-1 receptor antagonist in the synovial membrane and cartilage/pannus junction in rheumatoid arthritis. Br J Rheumatol 1992;31:801-9.
5. Firestein GS, Berger AE, Tracey DE, Chosay JG, Chapman DL, Paine MM, et al. IL-1 receptor antagonist protein production and gene expression in rheumatoid arthritis and osteoarthritis synovium. J Immunol 1992;149:1054-62.
6. Koch AE, Kunkel SL, Chensue SW, Haines GK, Strieter RM. Expression of interleukin-1 and interleukin-1 receptor antagonist by human rheumatoid synovial tissue macrophages. Clin Immunol Immunopathol 1992;65:23-9.
7. Arend WP, Malyak M, Guthridge CJ, Gabay C. Interleukin-1 receptor antagonist: Role in biology. Annu Rev Immunol 1998;16:27-55.
8. Bresnihan B, Alvaro-Gracia JM, Cobby M, Doherty M, Domljan Z, Emery P, et al. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum 1998;41:2196-204.
9. Felson DT, Anderson JJ, Boers M, Bombardier C, Furst O, Goldsmith C, et al. American college of rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727-35.
10. Jiang Y, Genant HK, Watt I, Cobby M, Bresnihan B, Aitchison R, McCabe D. A multicenter, double-blind, dose-ranging, randomized, and placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: Radiologic progression and correlation of genant and larsen scores. Arthritis Rheum 2000;43:1001-9.
11. Harris ED. Rheumatoid arthritis: Pathophysiology and implications for therapy. N Engl J Med 1990;332:1277-89.
12. Cunnane G, Madigan A, Murphy E, Fitzgerald O, Bresnihan B. The effects of treatment with interleukin-1 receptor antagonist on the inflamed synovial membrane in rheumatoid arthritis. Rheumatology 2001;40:62-9.
13. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996;87:2095-147.
14. Nuki G, Rozman B, Pavelka K, Emery P, Lookabaugh J, Musikic P. Interleukin-1 receptor antagonist continues to demonstrate clinical improvement in rheumatoid arthritis (abstr). Arthritis Rheum 1997;40:S224.
15. Cohen S, Hurd E, Cush JJ, Schiff MH, Weinblatt ME, Moreland LW, et al. Treatment of interleukin-1 receptor antagonist in combination with methotrexate in rheumatoid arthritis patients (abstr). Arthritis Rheum 1999;42:S273.
16. O'Dell JR. Anticytokine therapy: A new era in the treatment of rheumatoid arthritis? N Engl J Med 1999;340:310-2.